Merck KGaA operates in three key segments: healthcare, life science, and electronics. Over the past decade, strategic acquisitions and divestments have strengthened its position in these industries, ...
The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...
Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics. Optum Rx said the new ...
UnitedHealth started making these changes over the past year, and the company aims to apply them to all prescriptions by 2028 ...
The Print on MSN13h
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...
BioCryst Pharmaceuticals sues Hetero with claims of Orladeyo patent infringement. Orladeyo generated $437.7 million in revenue for BioCryst last year. BioCryst seeks court order to prevent FDA ...
On March 13, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed a five-year patent term extension (“PTE”) for ...
With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...
Generic Engineering Construction and Projects Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 144.86 Crore) operating in Construction sector. Generic Engineering ...
Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback